CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
NeoCure is developing innovative cancer treatments targeting specific mutations in non-small-cell lung cancer using engineered T-cells. The project aims to combine these therapies with optimized chemotherapy and mRNA vaccines to enhance tumor elimination in preclinical models.
Non-small-cell-lung-cancer (NSCLC) remains one of the most lethal cancers (≈1.5 million deaths annually), and current treatments fail to achieve universal, lasting remissions.
While immune checkpoint therapies have improved NSCLC outcomes, many patients either do not respond or relapse, underscoring an urgent need for new, more effective strategies.
NeoCure directly addresses this need by harnessing T-cell receptor (TCR) engineering to target tumor-specific neoantigens.
In our prior research (ER…
WEIZMANN INSTITUTE OF SCIENCE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
